Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Cash from Discontinued Operations (2018 - 2019)

Historic Cash from Discontinued Operations for Ironwood Pharmaceuticals (IRWD) over the last 5 years, with Q1 2019 value amounting to $11.4 million.

  • Ironwood Pharmaceuticals' Cash from Discontinued Operations changed N/A to $11.4 million in Q1 2019 from the same period last year, while for Dec 2019 it was $11.4 million, marking a year-over-year increase of 16527.28%. This contributed to the annual value of $11.4 million for FY2019, which is 376.02% down from last year.
  • As of Q1 2019, Ironwood Pharmaceuticals' Cash from Discontinued Operations stood at $11.4 million.
  • Ironwood Pharmaceuticals' 5-year Cash from Discontinued Operations high stood at $11.4 million for Q1 2019, and its period low was $2.6 million during Q3 2018.